Table 3.
Metabolites previously studied
| First author, Year Metabolite source | Main findings |
|---|---|
| Metabolomics studies | |
| Alonso, 201514 Human serum | Higher incident AF risk associated with higher concentrations of glycolithocholate sulfate and glycocholenate sulfate |
| De Souza, 20102 Canine atrial tissue | After 2 weeks of ventricular-tachypacing, ADP+ATP, alanine, betaine, glucose, glutamate, NAD+NADH, and taurine levels were increased and α-ketoisovalerate level was decreased |
| Mayer, 20081 Human atrial tissue | Higher concentrations of β-hydroxybuterate and glycine in the AF group compared to the sinus rhythm group |
| Non-metabolomics studies | |
| Tamariz, 20115 Human serum | Higher risk of AF associated with higher uric acid concentration |
| Neuman, 20079 Human plasma | Increased oxidation of glutathione and derivatives of reactive oxygen metabolites in the AF group compared to control |
| Ramlawai, 200710 Human atrial tissue, serum | Tissue: Higher peroxide level in the AF group compared to control Serum: Higher peroxide level in the AF group at 6 hours after surgery but not at post-operative day 4 |
| Mihm, 20018 Human atrial tissue | MM-CK activity was reduced and 3-nitrotyrosine concentration was increased in the AF group compared to control |
| Ausma, 20003 Goat atrial tissue | Phosphocreatine level dropped during the first 8 weeks of AF induction and then returned to normal at 16 weeks; levels of creatine, ATP, ADP, AMP, GDP, GTP, and NAD did not change significantly. |
| Uno, 19864 Canine plasma | cGMP concentration increased significantly with AF induction; cAMP concentration did not change |
ADP, adenosine diphosphate; AF, atrial fibrillation; ATP, adenosine triphosphate; cAMP, cyclic (c) adenosine monophosphate (AMP); cGMP, cyclic (c) guanosine monophosphate (GMP); GDP, guanosine diphosphate; GTP, guanosine triphosphate; NADH, nicotinamide adenine dinucleotide (NAD) + hydrogen (H); MM-CK, myofibrillar creatine kinase